Why the study?
Does the WI79-9 rotavirus vaccine prevent symptomatic rotavirus gastroenteritis in infants?
Population
325 infants, 2 to 8 months old at enrollment
Comparison
Live, attenuated bovine x human rotavirus… vs Placebo
Design
RCT, randomized, double-blind
Follow-up
7 days after each dose for adverse events, and during the…
Authors
Loading...
Supports infant use of WI79-9 to prevent severe rotavirus gastroenteritis; confirms high efficacy of this live attenuated vaccine in RCT.
Does the WI79-9 rotavirus vaccine prevent symptomatic rotavirus gastroenteritis in infants?
The WI79-9 rotavirus vaccine is safe and highly effective in preventing severe symptomatic rotavirus gastroenteritis in infants.
Treanor et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: